Skip to main content
Log in

Neurohumoral markers that predict the efficiency of pharmacologic therapy of depressive disorders

  • Clinical Neurochemistry
  • Published:
Neurochemical Journal Aims and scope Submit manuscript

    We’re sorry, something doesn't seem to be working properly.

    Please try refreshing the page. If that doesn't work, please contact support so we can address the problem.

Abstract

We present a comprehensive clinical and biological study of 46 patients with depressive disorder (F32-F33: depressive episode and recurrent depressive disorder) during pharmacotherapy. Neurohumoral factors (cortisol, brain-derived neurotrophic factor, serotonin, DHEA and its sulfated form) were determined in serum by ELISA. The severity of the current depressive episode was evaluated using the 17-point Hamilton Depression Rating Scale (HDRS-17); the pharmacotherapy efficacy was evaluated using the scale of the Clinical Global Impression (CGI Scale). We showed that before prescription of pharmacotherapy peripheral blood neurohumoral markers that characterize the state of stress-realizing and stress-limiting systems of the body may be considered as biological predictors of the effective pharmacotherapy of a current depressive episode and used as additional paraclinical examination methods. At higher concentrations of cortisol and serotonin associated with a decrease in the content of neurosteroid dehydroepiandrosterone, the high efficiency of the pharmacotherapy of depressive episode is predicted.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Krasnov, V.N., Rasstroistva affektivnogo spektra (Affective Disorders), Moscow: Prakticheskaya Meditsina, 2011.

    Google Scholar 

  2. Jentsch, M.C., Van Buel, E.M., Bosker, F.J., Gladkevich, A.V., Klein, H.C., Oude, Voshaar R.C., Ruhe, H.G., Eisel, U.L.M., and Schoevers, R.A., Biomark. Med, 2015, vol. 9, no. 3, pp. 277–297.

    Article  CAS  PubMed  Google Scholar 

  3. Thase, M.E., Dialogues Clin. Neurosci, 2014, vol. 16, no. 4, pp. 539–544.

    PubMed  PubMed Central  Google Scholar 

  4. Uzbekov, M.G., Gurovich, I.Ya., and Ivanova, S.A., Sots. I klin. psikhiatr, 2016, vol. 26, no. 1, pp. 77–94.

    Google Scholar 

  5. Ryadovaya, L.A., Gutkevich, E.V., Stoyanova, I.Ya., and Ivanova, S.A., TSPU Bulletin, 2009, no. 3, pp. 49–53.

    Google Scholar 

  6. Bokhan, N.A., Ivanova, S.A., and Levchuk, L.A., Serotoninovaya sistema v modulyatsii depressivnogo i agressivnogo povedeniya (Serotoninergic System in the Modulation of Agression), Tomsk, 2013.

    Google Scholar 

  7. Markopoulou, K., Papadopoulos, A., Juruena, M.F., Poon, L., Pariante, C.M., and Cleare, A.J., Psychoneuroendocrinology, 2009, vol. 34, no. 1, pp. 19–26.

    Article  CAS  PubMed  Google Scholar 

  8. Rivera-Baltanas, T., Olivares, J.M., Calado-Otero, M., Kalynchuk, L.E., Martinez-Villamarin, J.R., and Caruncho, H.J., J. Affect Disord, 2014, vol. 163, pp. 47–55.

    Article  CAS  PubMed  Google Scholar 

  9. Eckert, A., Mikoteit, T., Beck, J., Hemmeter, U.M., Brand, S., Schmitt, K., Bischof, R., Delini-Stula, A., and Holsboer-Trachsler, E., European Psychiatry, 2016, vol. 33, p. 410.

    Article  Google Scholar 

  10. Yoshimura, R., Kishi, T., and Suzuki, A., Prog. Neuropsychopharmacol. Biol. Psychiatry, 2011, vol. 35, no. 4, pp. 1022–1025.

    Article  CAS  PubMed  Google Scholar 

  11. Morita, T., Senzaki, K., Ishihara, R., Umeda, K., Iwata, N., Nagai, T., Hida, H., Nabeshima, T., Yukawa, K., Ozaki, N., and Noda, Y., Hum. Psychopharmacol, 2014, vol. 29, no. 3, pp. 280–286.

    Article  CAS  PubMed  Google Scholar 

  12. Shutov, A.A. and Bystrova, O.V., Zhurn. Nevrol. i psikhiatr. im. S.S. Korsakova, 2008, no. 10, pp. 49–54.

    Google Scholar 

  13. Dzyuba, A.N., Khaustova, E.A., and Bezsheiko, V.G., Ukr. Med. chasopi, vol. 88, pp. 121–125.

  14. Levchuk, L.A., Vyalova, N.M., Simutkin, G.G., Ivanova, S.A., and Bokhan, N.A., Vestnik Ural’Skoi akademicheskoi meditsinskoi nauki, 2014, no. 3, pp. 217–219.

    Google Scholar 

  15. Levchuk, L.A., Vyalova, N.M., Ivanova, S.A., Simutkin, G.G., Lebedeva, E.V., and Bokhan, N.A., Bulletin of Experimental Biology and Medicine, 2015, vol. 158, no. 5, pp. 638–640.

    Article  CAS  PubMed  Google Scholar 

  16. Levchuk, L.A., Ivanova, S.A., Simutkin, G.G., Lebedeva, E.V., Vyalova, N.M., Losenkov, I.S., and Bokhan, N.A., RF Patent No. 2530635 (2014).

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to S. A. Ivanova.

Additional information

Original Russian Text © L.A. Levchuk, N.M. Vyalova, G.G. Simutkin, N.A. Bokhan, S.A. Ivanova, 2017, published in Neirokhimiya, 2017, Vol. 34, No. 2, pp. 177–180.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Levchuk, L.A., Vyalova, N.M., Simutkin, G.G. et al. Neurohumoral markers that predict the efficiency of pharmacologic therapy of depressive disorders. Neurochem. J. 11, 185–187 (2017). https://doi.org/10.1134/S1819712417020088

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1134/S1819712417020088

Keywords

Navigation